Safety, Resource Use, and Quality of Life in Paramount: A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer

MLA

Martin Reck, et al. “Safety, Resource Use, and Quality of Life in Paramount: A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer.” Journal of Thoracic Oncology, vol. 7, no. 11, Nov. 2012, pp. 1713–21. EBSCOhost, https://doi.org/10.1097/jto.0b013e318267cf84.

APA

Martin Reck, Thierry Pieters, Filippo de Marinis, Katherine B. Winfree, Jean-Louis Pujol, Julie Beyrer, Luis Paz-Ares, Nadia Chouaki, Bárbara Parente, William J. John, Cesare Gridelli, Anna Zimmermann, Gary Middleton, Jesus Corral, Symantha Melemed, Carla Visseren-Grul, & Rodryg Ramlau. (2012). Safety, Resource Use, and Quality of Life in Paramount: A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology, 7(11), 1713–1721. https://doi.org/10.1097/jto.0b013e318267cf84

Chicago

Martin Reck, Thierry Pieters, Filippo de Marinis, Katherine B. Winfree, Jean-Louis Pujol, Julie Beyrer, Luis Paz-Ares, et al. 2012. “Safety, Resource Use, and Quality of Life in Paramount: A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer.” Journal of Thoracic Oncology 7 (11): 1713–21. doi:10.1097/jto.0b013e318267cf84.